These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 816464)

  • 21. Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline N-oxide.
    Hennings H; Shores R; Balaschak M; Yuspa SH
    Cancer Res; 1990 Feb; 50(3):653-7. PubMed ID: 2105160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of the skin of different mouse strains to the promoting effect of 12-0-tetradecanoyl-phorbol-13-acetate.
    Chouroulinkov I; Lasne C; Phillips D; Grover P
    Bull Cancer; 1988; 75(6):557-65. PubMed ID: 3137985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
    Yokota K; Gill TJ; Shinozuka H
    Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplacental skin tumor initiation of Ha/ICR mice at different fetal ages.
    Morris EP; Burns FJ; Albert RE
    Cancer Res; 1983 Sep; 43(9):4271-4. PubMed ID: 6409402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin.
    Szallasi Z; Krsmanovic L; Blumberg PM
    Cancer Res; 1993 Jun; 53(11):2507-12. PubMed ID: 8495413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate.
    Lutz WK; Beland PE; Candrian R; Fekete T; Fischer WH
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):44-8. PubMed ID: 8628919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of type of dietary fat on phorbol ester-elicited tumor promotion and other events in mouse skin.
    Leyton J; Lee ML; Locniskar M; Belury MA; Slaga TJ; Bechtel D; Fischer SM
    Cancer Res; 1991 Feb; 51(3):907-15. PubMed ID: 1899048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.
    Hsieh YH; Juliana MM; Hicks PH; Feng G; Elmets C; Liaw L; Chang PL
    Cancer Res; 2006 Jul; 66(14):7119-27. PubMed ID: 16849558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
    Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
    Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
    Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
    Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papilloma and carcinoma production in DMBA-initiated, onion oil-promoted mouse skin.
    Belman S; Sellakumar A; Bosland MC; Savarese K; Estensen RD
    Nutr Cancer; 1990; 14(2):141-8. PubMed ID: 2120683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of the formation of new hair follicles in mouse tail epidermis by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
    Schweizer J; Marks F
    Cancer Res; 1977 Nov; 37(11):4195-201. PubMed ID: 409492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical modeling of skin papilloma data in SENCAR mice.
    Watanabe KH; Travis CC
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):419-30. PubMed ID: 9439737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor promotion by a hydroperoxide metabolite of butylated hydroxytoluene, 2,6-di-tert-butyl-4-hydroperoxy-4-methyl-2,5-cyclohexadienone, in mouse skin.
    Taffe BG; Kensler TW
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):291-303. PubMed ID: 3141995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral administration of ciclosporin A on skin carcinogenesis: a study using the two-stage carcinogenesis protocol in mice.
    Yajima Y; Sueki H; Oguro T; Yoshida T; Iijima M
    Clin Exp Dermatol; 2008 Jul; 33(4):478-83. PubMed ID: 18498406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas.
    Klein-Szanto AJ; Nelson KG; Shah Y; Slaga TJ
    J Natl Cancer Inst; 1983 Jan; 70(1):161-8. PubMed ID: 6185712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of initiator-promoter-induced skin tumorigenesis in female SENCAR mice fed a vitamin A-deficient diet and reappearance of tumors in mice fed a diet adequate in retinoid or beta-carotene.
    De Luca LM; Shores RL; Spangler EF; Wenk ML
    Cancer Res; 1989 Oct; 49(19):5400-6. PubMed ID: 2504490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity to two-stage carcinogenesis of SENCAR mouse skin grafted to nude mice.
    Yuspa SH; Spangler EF; Donahoe R; Geusz S; Ferguson E; Wenk M; Hennings H
    Cancer Res; 1982 Feb; 42(2):437-9. PubMed ID: 6799187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-promoting activity of 2,3-dihydrophorbol myristate acetate and phorbolol myristate acetate in mouse skin.
    Segal A; Van Duuren BL; Maté U; Solomon JJ; Seidman I; Smith A; Melchionne S
    Cancer Res; 1978 Apr; 38(4):921-5. PubMed ID: 639046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.